Irina S. Yuzhakova
Irina S. Yuzhakova has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Mariya I. Pakharukova
Clinical and Diagnostic Center of Yekaterinburg
3 shared publications - Yu.V. Tsukanova
Clinical and Diagnostic Center named after Ya. B. Beikin
2 shared publications - Yulia G. Lagereva
Clinical and Diagnostic Center named after Ya. B. Beikin
2 shared publications - B. G. Yushkov
Institute of Immunology and Physiology of the Ural Branch of the RAS
1 shared publication Clinical And Diagnostic Center Of Yekaterinburg
1 shared publication- E. A. Artemyeva
Institute of Natural Sciences and Mathematics, Ural Federal University named after the first President of Russia B. N. Yeltsin
1 shared publication
Latest Publications
- Open Access
- 3 August 2025
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 21 (2) , 91-99
Efficiency of the immunocytochemical method for assessing p16 / Ki-67 coexpression in the diagnosis of cervical pathology
Background. Cervical intraepithelial lesion with human papillomavirus (HPV) is one of the most common HPV-associated diseases. In recent years, immunocytochemical detection of p16 / Ki-67 coexpression has been considered as an additional method for confirming precancerous and cancerous cervical lesions, with high sensitivity and specificity.Aim. To determine the detection rate of p16 / Ki-67 coexpression depending on the degree of intraepithelial lesion, human papillomavirus genotype, viral load, and the presence of coinfection. To calculate the performance indicators of the immunocytochemical method and the polymerase chain reaction method for detecting HPV DNA for the diagnosis of severe intraepithelial lesions and cervical carcinoma (cervical intraepithelial neoplasia, CIN 2+).Materials and methods. The study included material from 129 patients. Depending on the degree of cervical lesion, the following groups were formed: low-grade squamous intraepithelial lesion (CIN 1), high-grade squamous intraepithelial lesion (2–3), carcinoma. The comparison groups included patients without intraepithelial changes and with negative / positive results for HPV DNA. Coexpression of p16 / Ki-67 was assessed using immunocytochemistry, HPV DNA was determined by real-time polymerase chain reaction. The results were evaluated in comparison with histology. Results. The frequency of detection of positive p16 / Ki-67 immunocytochemistry depending on the degree of dysplasia and carcinoma of the cervix: CIN 1 – 26.5 % (n = 9), CIN 2 – 59.3 % (n = 16), CIN 3 – 88.2 % (n = 15), squamous cell carcinoma – 88.9 % (n = 8). Co-expression was more often detected in the presence of HPV infection of genotypes 16, 18 and 31. The median viral load was higher in the presence of double staining p16 / Ki-67 and amounted to 6.21 lg, in the absence of coexpression – 5.02 lg. No statistically significant differences were found in the frequency of detection of co-expression of p16 / Ki-67 depending on the number of HPV genotypes in the material. The efficiency indicators of the method for diagnosing CIN 2+ were: sensitivity 73.58 %, specificity 82.35 %.Conclusion. A positive coexpression of p16 / Ki-67 is more often detected in severe intraepithelial lesions of the cervix and the presence of HPV genotypes 16, 18 and 31. Immunocytochemical method of assessing p16 / Ki-67 coexpression is more specific in the diagnosis of precancerous and cancerous diseases of the cervix compared to the detection of HPV DNA.
- 3 August 2025
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 21 (2) , 91-99
Open AccessEfficiency of the immunocytochemical method for assessing p16 / Ki-67 coexpression in the diagnosis of cervical pathology
Background. Cervical intraepithelial lesion with human papillomavirus (HPV) is one of the most common HPV-associated diseases. In recent years, immunocytochemical detection of p16 / Ki-67 coexpression has been considered as an additional method for confirming precancerous and cancerous cervical lesions, with high sensitivity and specificity.Aim. To determine the detection rate of p16 / Ki-67 coexpression depending on the degree of intraepithelial lesion, human papillomavirus genotype, viral load, and the presence of coinfection. To calculate the performance indicators of the immunocytochemical method and the polymerase chain reaction method for detecting HPV DNA for the diagnosis of severe intraepithelial lesions and cervical carcinoma (cervical intraepithelial neoplasia, CIN 2+).Materials and methods. The study included material from 129 patients. Depending on the degree of cervical lesion, the following groups were formed: low-grade squamous intraepithelial lesion (CIN 1), high-grade squamous intraepithelial lesion (2–3), carcinoma. The comparison groups included patients without intraepithelial changes and with negative / positive results for HPV DNA. Coexpression of p16 / Ki-67 was assessed using immunocytochemistry, HPV DNA was determined by real-time polymerase chain reaction. The results were evaluated in comparison with histology. Results. The frequency of detection of positive p16 / Ki-67 immunocytochemistry depending on the degree of dysplasia and carcinoma of the cervix: CIN 1 – 26.5 % (n = 9), CIN 2 – 59.3 % (n = 16), CIN 3 – 88.2 % (n = 15), squamous cell carcinoma – 88.9 % (n = 8). Co-expression was more often detected in the presence of HPV infection of genotypes 16, 18 and 31. The median viral load was higher in the presence of double staining p16 / Ki-67 and amounted to 6.21 lg, in the absence of coexpression – 5.02 lg. No statistically significant differences were found in the frequency of detection of co-expression of p16 / Ki-67 depending on the number of HPV genotypes in the material. The efficiency indicators of the method for diagnosing CIN 2+ were: sensitivity 73.58 %, specificity 82.35 %.Conclusion. A positive coexpression of p16 / Ki-67 is more often detected in severe intraepithelial lesions of the cervix and the presence of HPV genotypes 16, 18 and 31. Immunocytochemical method of assessing p16 / Ki-67 coexpression is more specific in the diagnosis of precancerous and cancerous diseases of the cervix compared to the detection of HPV DNA.
- 28 December 2023
- Published by Media Sphere Publishing Group in Laboratory Service
- Vol. 12 (4)
Diagnostic assessment of the cytological method in the diagnosis of glandular lesions during cervical screening: the results of a retrospective single-center analysis
Атипичные железистые клетки (AGC) — редкое цитологическое заключение при цервикальном скрининге. Диагностика железистых поражений представляет ряд трудностей. Появившиеся в последние годы исследования обсуждают необходимость подкатегорий AGC ввиду их разной прогностической значимости. ЦЕЛЬ РАБОТЫ Оценить частоту встречаемости атипичных железистых клеток у пациенток с впервые выявленным раком тела матки, показатели эффективности цитологического метода в диагностике железистых поражений, а также клиническую значимость подкатегорий AGC. МАТЕРИАЛ И МЕТОДЫ Для оценки частоты обнаружения клеток эндометрия при цервикальном скрининге у пациенток с раком тела матки включены результаты 197 обследованных за 2021—2022 гг. Проведен сравнительный ретроспективный анализ результатов цитологического исследования 320 мазков с последующим гистологическим исследованием материала в период с 2018 по 2022 г. Произведен расчет показателей эффективности цитологического метода. РЕЗУЛЬТАТЫ Клетки эндометрия у пациенток с подтвержденным раком тела матки при цервикальном скрининге обнаруживались в 41,1% случаев. Чувствительность цитологического метода исследования в диагностике железистых поражений составила 83,8% (95% ДИ 77,7—88,8%), специфичность — 88,8% (95% ДИ 82,2—93,60%), PPV — 91,2% (95% ДИ 85,7—94,98%), NPV — 79,9% (95% ДИ 72,5—85,9%). Получены статистически значимые различия вероятности обнаружения злокачественного новообразования или неопластического процесса в зависимости от цитологического заключения в следующих категориях: NILM, EM и ADC, EM (pp=0,019); AGC NOS, EM и ADC, EM (pp=0,009). ЗАКЛЮЧЕНИЕ Цитологический метод обладает высокими показателями эффективности для диагностики железистых поражений. При подразделении категории AGC NOS на EC/EM и AGC FN на EC/EM возрастает прогностическая значимость цитологического заключения для дальнейшего обследования пациенток.
- 28 December 2023
- Published by Media Sphere Publishing Group in Laboratory Service
- Vol. 12 (4)
Diagnostic assessment of the cytological method in the diagnosis of glandular lesions during cervical screening: the results of a retrospective single-center analysis
Атипичные железистые клетки (AGC) — редкое цитологическое заключение при цервикальном скрининге. Диагностика железистых поражений представляет ряд трудностей. Появившиеся в последние годы исследования обсуждают необходимость подкатегорий AGC ввиду их разной прогностической значимости. ЦЕЛЬ РАБОТЫ Оценить частоту встречаемости атипичных железистых клеток у пациенток с впервые выявленным раком тела матки, показатели эффективности цитологического метода в диагностике железистых поражений, а также клиническую значимость подкатегорий AGC. МАТЕРИАЛ И МЕТОДЫ Для оценки частоты обнаружения клеток эндометрия при цервикальном скрининге у пациенток с раком тела матки включены результаты 197 обследованных за 2021—2022 гг. Проведен сравнительный ретроспективный анализ результатов цитологического исследования 320 мазков с последующим гистологическим исследованием материала в период с 2018 по 2022 г. Произведен расчет показателей эффективности цитологического метода. РЕЗУЛЬТАТЫ Клетки эндометрия у пациенток с подтвержденным раком тела матки при цервикальном скрининге обнаруживались в 41,1% случаев. Чувствительность цитологического метода исследования в диагностике железистых поражений составила 83,8% (95% ДИ 77,7—88,8%), специфичность — 88,8% (95% ДИ 82,2—93,60%), PPV — 91,2% (95% ДИ 85,7—94,98%), NPV — 79,9% (95% ДИ 72,5—85,9%). Получены статистически значимые различия вероятности обнаружения злокачественного новообразования или неопластического процесса в зависимости от цитологического заключения в следующих категориях: NILM, EM и ADC, EM (pp=0,019); AGC NOS, EM и ADC, EM (pp=0,009). ЗАКЛЮЧЕНИЕ Цитологический метод обладает высокими показателями эффективности для диагностики железистых поражений. При подразделении категории AGC NOS на EC/EM и AGC FN на EC/EM возрастает прогностическая значимость цитологического заключения для дальнейшего обследования пациенток.
- Open Access
- 1 January 2021
- Published by Bulletin of the Ural Medical Academie Science in Journal of Ural Medical Academic Science
- Vol. 18 (2)
Vulvar Squamous Cell Carcinoma: the Relevance of Tumor HPV-Status
The purpose of the study was to study the role of human papillomavirus (HPV) in the etiopathogenesis of vulvar squamous cell carcinoma and it significance for survival and treatment. Material and Methods. The relevant sources were searched and analyzed in the PubMed, Cochrane Library and e-library systems from 2000 to 2021. Results. True estimation of the DNA HPV and his prognostic role in vulvar cancer has not been fully understood yet and still debatable. The inconsistent results may be due to the low frequency of the tumor and, in connection with this, the small sample of patients for the study as well as the limited geography of the study. Conclusion. Further study of HPV infection as a biomarker for predicting the course of the disease is of great interest, since the HPV status can be used to select treatment tactics as well as to monitor patients.
- 1 January 2021
- Published by Bulletin of the Ural Medical Academie Science in Journal of Ural Medical Academic Science
- Vol. 18 (2)
Open AccessVulvar Squamous Cell Carcinoma: the Relevance of Tumor HPV-Status
The purpose of the study was to study the role of human papillomavirus (HPV) in the etiopathogenesis of vulvar squamous cell carcinoma and it significance for survival and treatment. Material and Methods. The relevant sources were searched and analyzed in the PubMed, Cochrane Library and e-library systems from 2000 to 2021. Results. True estimation of the DNA HPV and his prognostic role in vulvar cancer has not been fully understood yet and still debatable. The inconsistent results may be due to the low frequency of the tumor and, in connection with this, the small sample of patients for the study as well as the limited geography of the study. Conclusion. Further study of HPV infection as a biomarker for predicting the course of the disease is of great interest, since the HPV status can be used to select treatment tactics as well as to monitor patients.